GlassScriptPhysician profile
Maurice T Zagha
NPI 1457442659
$5,441.73
in general payments reported to CMS, 2019-2025
21 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,016 · 2020: $821 · 2021: $926 · 2022: $718 · 2023: $1,407 · 2024: $553.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,960.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,960.33 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $1,667.33 | 2019-2024 | Spravato |
| Abbvie INC. | $651.45 | 2021-2024 | Qulipta, Ubrelvy |
| Amgen INC. | $566.63 | 2019-2024 | Evenity, Repatha |
| Merck Sharp & Dohme LLC | $362.00 | 2019-2023 | Verquvo, Belsomra |
| Boehringer Ingelheim Pharmaceuticals, INC. | $262.33 | 2019-2023 | Jardiance |
| Intuitive Surgical, INC. | $260.89 | 2020-2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $239.36 | 2020-2021 | |
| Astrazeneca Pharmaceuticals LP | $237.17 | 2022-2023 | Breztri, Farxiga |
| Abbott Laboratories | $232.99 | 2023-2024 | Freestyle Libre 3 |
| Edwards Lifesciences Corporation | $203.30 | 2023-2024 | Edwards Sapien 3 Transcatheter Heart Valve (Thv) |
| Glaxosmithkline, LLC. | $146.55 | 2022 | |
| Lilly USA, LLC | $144.92 | 2020-2023 | Mounjaro |
| Novo Nordisk INC | $139.03 | 2019-2023 | Wegovy |
| Pfizer INC. | $93.82 | 2019-2021 | |
| Otsuka America Pharmaceutical, INC. | $54.27 | 2023-2024 | Rexulti |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Corcept Therapeutics | $50.00 | 2021 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $45.34 | 2023 | Xifaxan |
| Boston Scientific Corporation | $28.88 | 2020 | |
| Boehringer Ingelheim International Gmbh | $21.83 | 2024 | |
| Sanofi-Aventis U.S. LLC | $18.52 | 2019 | |
| Medicure Pharma INC. | $15.12 | 2023 | Zypitamag |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Maurice Zagha listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.